H.R. 2855 · 116th Congress

To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.

Stage
In committee
Sponsor
Steve King
Introduced
2019-05-20
Latest action
2019-05-21 · Referred to the Subcommittee on Health.

Action history

  1. 2019-05-21Referred to the Subcommittee on Health.
  2. 2019-05-20Introduced in House
  3. 2019-05-20Referred to the House Committee on Energy and Commerce.